Meyka Pro banner
Cabot Corp.

Cabot Corp. (CBT) Stock Overview

Explore Cabot Corp.’s financial performance, market position, analyst ratings, and future outlook.

CBT●NYSE
Basic MaterialsChemicals - Specialty
$77.76
$0.69(0.88%)
U.S. Market opens in 14h 22m

Cabot Corp. (CBT)

Meyka AI Score

Z

Key Financials

Market Cap4B
P/E Ratio21.66
EPS (TTM)$6.51
ROE0.12%
Fundamental Analysis

AI Price Forecasts

1 Month$69.99
3 Months$80.98
1 Year Target$69.61

CBT Stock Analysis & Investment Overview (NYSE)

Our AI-powered analysis of Cabot Corp. (NYSE: CBT) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Cabot Corp.'s NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of CBT on the NYSE shows an RSI of 38.44, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $69.61 for the NYSE listing.

Key metrics behind Cabot Corp.'s NYSE-traded stock include a P/E ratio of 21.66 and a market capitalization of 4B. Combined with our AI analysis, these give both institutional and retail investors a clear view of CBT on the NYSE.

Price Performance (NYSE: CBT)

1-Day Change
-0.88%
5-Day Change
-0.97%
1-Month Change
-7.04%
3-Month Change
-13.94%
6-Month Change
4.93%
Year-to-Date (YTD) Change
17.32%
1-Year Change
2.03%
3-Year Change
12.26%
5-Year Change
51.08%
All-Time (Max) Change
7676.00%

Contact Information

617-345-0100
Two Seaport Lane, Boston, MA, 02210-2019

Company Facts

40,640 Employees
IPO DateNov 5, 1980
CountryUS
Actively Trading

Frequently Asked Questions